Cargando…

Hemangiopericytoma of the central nervous system: a case report

Hemangiopericytomas or solitary meningeal fibrous tumors are extremely rare mesenchymal tumors. They represent only 1.6% of all central nervous system tumors, occurring mainly in adults between 40 and 50 years of age with a slight male predominance. We report the observation of a 20-year-old man tre...

Descripción completa

Detalles Bibliográficos
Autores principales: Moukhlissi, Mohamed, Elouaouch, Sofia, Aichouni, Narjiss, Berhili, Soufiane, Mezouar, Loubna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The African Field Epidemiology Network 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148174/
https://www.ncbi.nlm.nih.gov/pubmed/37128618
http://dx.doi.org/10.11604/pamj.2023.44.58.36813
_version_ 1785034942769528832
author Moukhlissi, Mohamed
Elouaouch, Sofia
Aichouni, Narjiss
Berhili, Soufiane
Mezouar, Loubna
author_facet Moukhlissi, Mohamed
Elouaouch, Sofia
Aichouni, Narjiss
Berhili, Soufiane
Mezouar, Loubna
author_sort Moukhlissi, Mohamed
collection PubMed
description Hemangiopericytomas or solitary meningeal fibrous tumors are extremely rare mesenchymal tumors. They represent only 1.6% of all central nervous system tumors, occurring mainly in adults between 40 and 50 years of age with a slight male predominance. We report the observation of a 20-year-old man treated at the Oujda Regional Oncology Center for cerebral hemangiopericytoma, revealed by headaches resistant to usual analgesic treatments without other associated signs. Initial imaging a left temporo-parieto-occipital intraaxial tumor process all responsible for a sub-falcoial and temporal engagement whose appearance first evokes a high-grade glial tumor. The patient received a complete excision whose pathological examination with immunohistochemical study was in favor of a grade III hemangiopericytoma according to the WHO 2016 classification. Therapeutic management with adjuvant radiotherapy was supplemented with a volumetric modulated arc therapy (VMAT) technique at a total dose of 54Gy. We will discuss through this case, the clinical and therapeutic peculiarities by a review of the literature.
format Online
Article
Text
id pubmed-10148174
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The African Field Epidemiology Network
record_format MEDLINE/PubMed
spelling pubmed-101481742023-04-30 Hemangiopericytoma of the central nervous system: a case report Moukhlissi, Mohamed Elouaouch, Sofia Aichouni, Narjiss Berhili, Soufiane Mezouar, Loubna Pan Afr Med J Case Report Hemangiopericytomas or solitary meningeal fibrous tumors are extremely rare mesenchymal tumors. They represent only 1.6% of all central nervous system tumors, occurring mainly in adults between 40 and 50 years of age with a slight male predominance. We report the observation of a 20-year-old man treated at the Oujda Regional Oncology Center for cerebral hemangiopericytoma, revealed by headaches resistant to usual analgesic treatments without other associated signs. Initial imaging a left temporo-parieto-occipital intraaxial tumor process all responsible for a sub-falcoial and temporal engagement whose appearance first evokes a high-grade glial tumor. The patient received a complete excision whose pathological examination with immunohistochemical study was in favor of a grade III hemangiopericytoma according to the WHO 2016 classification. Therapeutic management with adjuvant radiotherapy was supplemented with a volumetric modulated arc therapy (VMAT) technique at a total dose of 54Gy. We will discuss through this case, the clinical and therapeutic peculiarities by a review of the literature. The African Field Epidemiology Network 2023-01-31 /pmc/articles/PMC10148174/ /pubmed/37128618 http://dx.doi.org/10.11604/pamj.2023.44.58.36813 Text en Copyright: Mohamed Moukhlissi et al. https://creativecommons.org/licenses/by/4.0/The Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Case Report
Moukhlissi, Mohamed
Elouaouch, Sofia
Aichouni, Narjiss
Berhili, Soufiane
Mezouar, Loubna
Hemangiopericytoma of the central nervous system: a case report
title Hemangiopericytoma of the central nervous system: a case report
title_full Hemangiopericytoma of the central nervous system: a case report
title_fullStr Hemangiopericytoma of the central nervous system: a case report
title_full_unstemmed Hemangiopericytoma of the central nervous system: a case report
title_short Hemangiopericytoma of the central nervous system: a case report
title_sort hemangiopericytoma of the central nervous system: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10148174/
https://www.ncbi.nlm.nih.gov/pubmed/37128618
http://dx.doi.org/10.11604/pamj.2023.44.58.36813
work_keys_str_mv AT moukhlissimohamed hemangiopericytomaofthecentralnervoussystemacasereport
AT elouaouchsofia hemangiopericytomaofthecentralnervoussystemacasereport
AT aichouninarjiss hemangiopericytomaofthecentralnervoussystemacasereport
AT berhilisoufiane hemangiopericytomaofthecentralnervoussystemacasereport
AT mezouarloubna hemangiopericytomaofthecentralnervoussystemacasereport